Zhongke Biotech (01237) announced interim results. Profit attributable to shareholders of 15.72 million yuan increased 79.62% year-on-year

Zhitongcaijing · 3d ago

According to the Zhitong Finance App, Zhongke Biotech (01237) announced the 2026 interim results. The group achieved revenue of RMB 242 million during the period, an increase of 21.27% over the previous year; profit attributable to company owners was 15.72 million yuan, an increase of 79.62% over the previous year; and the basic profit per share was 0.1,637 yuan.